Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Aug;1450(1):69-82.
doi: 10.1111/nyas.14112. Epub 2019 May 31.

Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta-analysis

Jenny Jung  1   2 , Md Mizanur Rahman  1   2 , Md Shafiur Rahman  1   2 , Khin Thet Swe  1 , Md Rashedul Islam  1   2 , Md Obaidur Rahman  2 , Shamima Akter  2   3
Affiliations
Meta-Analysis

Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta-analysis

Jenny Jung et al. Ann N Y Acad Sci. 2019 Aug.

Abstract

Maternal anemia affects approximately 56 million women worldwide and increases the risk of adverse pregnancy outcomes. Our study aimed to summarize the evidence for the association between maternal hemoglobin (Hb) concentrations and maternal or infant outcomes, evaluating it in a continuous manner. In this systematic review and meta-analysis, we conducted an electronic search on PubMed, Embase, CINAHL, and Web of Science from inception to April 19, 2017, and further updated to November 21, 2018, applying subject heading terms related to pregnant women with anemia. We included 117 studies with 4,127,430 pregnancies. Maternal anemia increased the risk of low birth weight (odds ratio (OR), 1.65; 95% confidence interval (CI): 1.45-1.87), preterm birth (PTB) (OR, 2.11; 95% CI: 1.76-2.53), perinatal mortality (PNM) (OR, 3.01; 95% CI: 1.92-4.73), stillbirth (OR, 1.95; 95% CI: 1.15-3.31), and maternal mortality (OR, 3.20; 95% CI: 1.16-8.85). A nonlinear relationship was found between maternal Hb and adverse maternal and infant outcomes. The OR of outcomes such as PTB, small-for-gestational age, PNM, preeclampsia, gestational hypertension, and postpartum hemorrhage was increased by two to three times. Assessing Hb as a continuous variable is important to determine the associated risk of adverse outcomes with decreasing or increasing levels.

Keywords: anemia; dose−response analysis; hemoglobin concentration; infant outcomes; random-effects meta-analysis.

PubMed Disclaimer

References

    1. Global Health Observatory Data Repository. Prevalence of anaemia in pregnant women. Estimates by WHO region [online]. Accessed September 14, 2018. http://apps.who.int/gho/data/view.main.ANAEMIAWOMENPWREG.
    1. New, S. & M. Wirth. 2015. Anaemia, pregnancy, and maternal mortality: the problem with globally standardised haemoglobin cutoffs. BJOG 122: 166-169.
    1. Breymann, C., X.M. Bian, L.R. Bianco-Capito, et al. 2011. Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. J. Perinat. Med. 39: 113-121.
    1. Rahman, M.M., S.K. Abe, M.S. Rahman, et al. 2016. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am. J. Clin. Nutr. 103: 495-504.
    1. Wells, G., B. Shea, D. O'connell, et al. 2014.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. The World Bank. Accessed July 26, 2017. http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf.

Publication types

LinkOut - more resources